ECRM_1170x120_8-1-17

David Denton

With Aetna deal nearing, CVS names new team

With Aetna deal nearing, CVS names new team

WOONSOCKET, R.I.­ — CVS Health has announced the management team that, following the close of the Aetna acquisition, will lead the combined company into the future. Aetna will operate as a stand-alone business unit within the CVS Health enterprise following the close and will be led by members of its current management team. In addition,

CVS Health sees solid finish to 2017 fiscal year

CVS Health sees solid finish to 2017 fiscal year

WOONSOCKET, R.I. — Driven by growth in its pharmacy benefit management unit, and overcoming softness in its retail business, CVS Health posted increased sales and beat Wall Street’s earnings forecast for its 2017 fourth quarter and fiscal year. CVS said Thursday that for the fourth quarter ended Dec. 31, total revenue rose 5.3% to $48.39

CVS Health unveils outlook for fiscal 2018

WOONSOCKET, R.I. — CVS Health executives expressed confidence in the company’s growth strategy earlier this month, and also noted that the recently passed tax overhaul packaged should boost its cash flow by an estimated $1.2 billion. The remarks came in a conference call following an announcement of CVS Health’s 2018 earnings outlook. CVS Health said

CVS Health gives update on 2018 outlook

CVS Health gives update on 2018 outlook

WOONSOCKET, R.I. — In an update for investors, CVS Health executives expressed confidence in its growth outlook and noted that the recently passed tax overhaul package should boost its cash flow by an estimated $1.2 billion. The remarks came yesterday in a conference call after the company’s announcement of its earnings expectations for 2018. CVS

Jury still out on WBA-Rite Aid merger deal

Jury still out on WBA-Rite Aid merger deal

WASHINGTON — The acquisition of Rite Aid Corp. by Walgreens Boots Alliance (WBA) Inc. remained unconsummated after WBA’s plan to divest 865 stores failed to erase antitrust regulators’ competitive concerns. When the Friday, January 27, deadline for completing the Walgreens-Rite Aid merger deal arrived, the Federal Trade Commission still hadn’t cleared the transaction, despite the

CVS well positioned to create value in health care

CVS well positioned to create value in health care

NEW YORK — CVS Health has raised the midpoint of its earnings outlook for 2016 and reiterated its five-year steady state targets. The company now expects next year’s adjusted earnings per share to range from $5.73 to $5.88, reflecting solid year-over-year growth of 11.25% to 14.25%. The bottom end of the range was increased by

Investment pros: Merlo is top food/drug retail CEO

Investment pros: Merlo is top food/drug retail CEO

Larry Merlo, president and chief executive officer of CVS Health, was named the No. 1 CEO in the food/drug retailing sector by Institutional Investor magazine. Merlo was part of the financial publication’s “2016 All-America Executive Team,” in which more than 2,000 portfolio managers and analysts were asked to name the best CEOs, CFOs and investor